Skip to main content

Table 2 Detection of individual high-risk and low-risk HPV genotypes by CLART and LA in 401 women with abnormal cytology

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

Genotype

Prevalence

Agreement

CLART, N (%)

LA, N (%)

Relative prevalence CLART vs. LA (95% CI)

CLART+/LA+

CLART+/LA-

CLART-/LA+

CLART-/LA-

Total agreement (95% CI)

Positive agreement (95% CI)

High-risk

         

16

121 (30%)

126 (31%)

0.96 (0.78-1.18)

120 (30%)

1 (0%)

6 (1%)

274 (68%)

98% (96-99)

94% (89-98)

18

45 (11%)

53 (13%)

0.85 (0.59-1.23)

45 (11%)

0 (0%)

8 (2%)

348 (87%)

98% (96-99)

85% (72-93)

31

64 (16%)

61 (15%)

1.05 (0.76-1.45)

61 (15%)

3 (1%)

0 (0%)

337 (84%)

99% (98-100)

95% (87-99)

33

42 (10%)

40 (10%)

1.05 (0.70-1.58)

39 (10%)

3 (1%)

1 (0%)

358 (89%)

99% (97-100)

91% (78-97)

35

19 (5%)

16 (4%)

1.19 (0.62-2.28)

16 (4%)

3 (1%)

0 (0%)

382 (95%)

99% (98-100)

84% (60-97)

39

22 (5%)

48 (12%)

0.46 (0.28-0.74)

22 (5%)

0 (0%)

26 (6%)

353 (88%)

94% (91-96)

46% (31-61)

45

16 (4%)

35 (9%)

0.46 (0.26-0.81)

16 (4%)

0 (0%)

19 (5%)

366 (91%)

95% (93-97)

46% (29-63)

51

47 (12%)

50 (12%)

0.94 (0.65-1.37)

46 (11%)

1 (0%)

4 (1%)

350 (87%)

99% (97-100)

90% (79-97)

52

49 (12%)

40 (10%)

1.23 (0.83-1.82)

33 (8%)

16 (4%)

7 (2%)

345 (86%)

94% (92-96)

59% (45-72)

56

30 (7%)

39 (10%)

0.77 (0.49-1.21)

27 (7%)

3 (1%)

12 (3%)

359 (90%)

96% (94-98)

64% (48-78)

58

59 (15%)

40 (10%)

1.48 (1.01-2.15)

38 (9%)

21 (5%)

2 (0%)

340 (85%)

94% (92-96)

62% (49-74)

59

27 (7%)

29 (7%)

0.93 (0.56-1.54)

20 (5%)

7 (2%)

9 (2%)

365 (91%)

96% (94-98)

56% (38-72)

68

25 (6%)

16 (4%)

1.56 (0.85-2.88)

6 (1%)

19 (5%)

10 (2%)

366 (91%)

93% (90-95)

17% (7-34)

Low-risk

         

6

15 (4%)

13 (3%)

1.15 (0.56-2.39)

12 (3%)

3 (1%)

1 (0%)

385 (96%)

99% (97-100)

75% (48-93)

11

4 (1%)

4 (1%)

1.00 (0.25-3.97)

4 (1%)

0 (0%)

0 (0%)

397 (99%)

100% (99-100)

100% (40-100)

26

3 (1%)

3 (1%)

1.00 (0.20-4.93)

3 (1%)

0 (0%)

0 (0%)

398 (99%)

100% (99-100)

100% (29-100)

40

5 (1%)

6 (1%)

0.83 (0.26-2.71)

5 (1%)

0 (0%)

1 (0%)

395 (99%)

100% (99-100)

83% (36-100)

42

20 (5%)

28 (7%)

0.71 (0.41-1.25)

20 (5%)

0 (0%)

8 (2%)

373 (93%)

98% (96-99)

71% (51-87)

53

50 (12%)

52 (13%)

0.96 (0.67-1.38)

48 (12%)

2 (0%)

4 (1%)

347 (87%)

99% (97-99)

89% (77-96)

54

15 (4%)

36 (9%)

0.42 (0.23-0.75)

14 (3%)

1 (0%)

22 (5%)

364 (91%)

94% (92-96)

38% (22-55)

61

34 (8%)

44 (11%)

0.77 (0.50-1.18)

34 (8%)

0 (0%)

10 (2%)

357 (89%)

98% (95-99)

77% (62-89)

62

12 (3%)

30 (7%)

0.40 (0.21-0.77)

12 (3%)

0 (0%)

18 (4%)

371 (93%)

96% (93-97)

40% (23-59)

66

44 (11%)

40 (10%)

1.10 (0.73-1.65)

37 (9%)

7 (2%)

3 (1%)

354 (88%)

98% (95-99)

79% (64-89)

70

28 (7%)

24 (6%)

1.17 (0.69-1.98)

24 (6%)

4 (1%)

0 (0%)

373 (93%)

99% (97-100)

86% (67-96)

71

1 (0%

2 (0%)

0.50 (0.05-5.49)

0 (0%)

1 (0%)

2 (0%)

398 (99%)

99% (98-100)

0% (0-71)

72

1 (0%)

1 (0%)

1.00 (0.06-15.93)

1 (0%)

0 (0%)

0 (0%)

400 (100%)

100% (99-100)

100% (3-100)

73

11 (3%)

31 (8%)

0.35 (0.18-0.70)

11 (3%)

0 (0%)

20 (5%)

370 (92%)

95% (92-97)

35% (19-55)

81

12 (3%)

14 (3%)

0.86 (0.40-1.83)

12 (3%)

0 (0%)

2 (0%)

387 (97%)

100% (98-100)

86% (57-98)

82

47 (12%)

21 (5%)

2.24 (1.36-3.67)

20 (5%)

27 (7%)

1 (0%)

353 (88%)

93% (90-95)

42% (28-57)

83

15 (4%)

14 (3%)

1.07 (0.52-2.19)

12 (3%)

3 (1%)

2 (0%)

384 (96%)

99% (97-100)

71% (44-90)

84

15 (4%)

26 (6%)

0.58 (0.31-1.07)

15 (4%)

0 (0%)

11 (3%)

375 (94%)

97% (95-99)

58% (37-77)